[
  {
    "ts": "2025-08-26T17:26:51+00:00",
    "headline": "Amgen (AMGN) Gains FDA Approval For Broadened Repatha® Use In Cardiovascular Risk Management",
    "summary": "Amgen (AMGN) recently received an expanded FDA approval for Repatha®, broadening its use for adults at risk of major cardiovascular events. During the same quarter, the company reported significant earnings growth, with Q2 revenue rising to $9,179 million. Despite a 3% price increase over the last quarter, the overall market showed a 15% annual growth trend, which suggests that Amgen’s developments in expanding product approvals and strong earnings may have contributed positively, aligning...",
    "url": "https://finance.yahoo.com/news/amgen-amgn-gains-fda-approval-172651289.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "8a4ccf89-95f1-36f3-8730-620be3847cb2",
      "content": {
        "id": "8a4ccf89-95f1-36f3-8730-620be3847cb2",
        "contentType": "STORY",
        "title": "Amgen (AMGN) Gains FDA Approval For Broadened Repatha® Use In Cardiovascular Risk Management",
        "description": "",
        "summary": "Amgen (AMGN) recently received an expanded FDA approval for Repatha®, broadening its use for adults at risk of major cardiovascular events. During the same quarter, the company reported significant earnings growth, with Q2 revenue rising to $9,179 million. Despite a 3% price increase over the last quarter, the overall market showed a 15% annual growth trend, which suggests that Amgen’s developments in expanding product approvals and strong earnings may have contributed positively, aligning...",
        "pubDate": "2025-08-26T17:26:51Z",
        "displayTime": "2025-08-26T17:26:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ACuIXYrNeojUXbAJFhnPIg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/B7CQJIEa.2c0sQ0XIU66pg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-amgn-gains-fda-approval-172651289.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-amgn-gains-fda-approval-172651289.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-26T12:06:00+00:00",
    "headline": "AMGN Up Almost 14% YTD: Should You Buy, Sell or Hold the Stock?",
    "summary": "Amgen's stock is up 13.5% in 2025, fueled by strong drug sales and new biosimilars, but looming competition and pricing headwinds pose challenges.",
    "url": "https://finance.yahoo.com/news/amgn-almost-14-ytd-buy-120600074.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "4bddf716-3520-3eda-8b1b-d0e22b2bd1e1",
      "content": {
        "id": "4bddf716-3520-3eda-8b1b-d0e22b2bd1e1",
        "contentType": "STORY",
        "title": "AMGN Up Almost 14% YTD: Should You Buy, Sell or Hold the Stock?",
        "description": "",
        "summary": "Amgen's stock is up 13.5% in 2025, fueled by strong drug sales and new biosimilars, but looming competition and pricing headwinds pose challenges.",
        "pubDate": "2025-08-26T12:06:00Z",
        "displayTime": "2025-08-26T12:06:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/7bc8bbeae2e0a87a69be234f543981cd",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cgmrsy.RXPZzY7yMaDwZPA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7bc8bbeae2e0a87a69be234f543981cd.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HTl0ikZ844wasPEHHtWO1A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7bc8bbeae2e0a87a69be234f543981cd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgn-almost-14-ytd-buy-120600074.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgn-almost-14-ytd-buy-120600074.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]